{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:55:28Z","timestamp":1792166128365,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi261065-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The prevalence of youths with mental health conditions has increased in recent years. Youths with mental health conditions are at risk of substance misuse via coping and self-regulation pathways; there is therefore a need to identify and address barriers to integrated mental health and substance use treatment in these youths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the prevalence of and motivations for prescription psychotherapeutic drug misuse among youths with and without depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A cross-sectional analysis of the 2023 and 2024 National Survey on Drug Use and Health (NSDUH) using a nationally representative survey of noninstitutionalized individuals aged 12 years and older related to drugs of misuse and mental health disorders. Data on adolescents and young adults were analyzed from January to March 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Past-year major depressive episode (MDE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-8\">\n                    <jats:title>Main Outcomes and Measure<\/jats:title>\n                    <jats:p>\n                      The primary outcome was past-year prescription psychotherapeutic drug misuse and use disorder, and the secondary outcome was motivations for misuse. Survey-weighted prevalence estimates with 95% CIs were calculated and group differences were assessed using \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests. To assess the association between drug misuse and depression, logistic regression models were used.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 2023 and 2024 NSDUH included 22\u202f906 adolescents (aged 12-17 years) and 27\u202f723 young adults (aged 18-25 years), among whom 24\u202f831 (49.1%) were males, 13\u202f256 (26.2%) were Hispanic, 6923 (13.7%) were non-Hispanic Black, 23\u202f114 (45.6%) were non-Hispanic White, and 7336 (14.5%) were non-Hispanic\u2013all other races. A past-year MDE was reported by 16.3% (95% CI, 15.6%-17.0%) of respondents, corresponding to an estimated 9.8 million individuals nationally. Among youths with a past-year MDE, 6.6% (95% CI, 5.8%-7.5%) reported misuse of psychotherapeutic drugs while 6.0% (95% CI, 5.2%-6.9%) reported use disorder. Youths with a past-year MDE had significantly higher odds of reporting prescription drug misuse (odds ratio [OR], 2.09; 95% CI, 1.75-2.50) and prescription drug use disorder (OR, 4.02; 95% CI, 3.37-4.80) compared with those without a past-year MDE. Compared with youths without a past-year MDE, youths with a past-year MDE were more likely to report misusing opioid analgesics (10.2% [95% CI, 6.4%-15.9%] vs 3.7% [95% CI, 2.2%-6.3%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.01) and tranquilizers (29.8% [95% CI, 21.1%-40.3%] vs 13.2% [95% CI, 5.8%-19.9%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.003) to help with feelings and emotions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi261065-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cross-sectional analysis of the 2023 and 2024 NSDUH found that youths with depression were more likely than their peers without depression both to report prescription drug misuse and to meet criteria for prescription drug use disorder. For certain medications, this misuse was more often motivated by a desire to address feelings and emotions. These findings underscore the need to identify and address barriers to integrated mental health and substance use treatment for at-risk youths before patterns of self-medication progress to enduring substance use disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.39343","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:30:30Z","timestamp":1792164630000},"page":"e2639343","source":"Crossref","is-referenced-by-count":0,"title":["Substance Misuse Prevalence and Risk Factors in Adolescents and Young Adults With Depression"],"prefix":"10.1001","volume":"9","author":[{"given":"Michael S.","family":"Toce","sequence":"first","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Massachusetts"},{"name":"Harvard Medical Toxicology Program, Boston Children\u2019s Hospital, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Porter","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Massachusetts"},{"name":"Harvard Medical Toxicology Program, Boston Children\u2019s Hospital, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence T.","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Computational Health Informatics Program, Boston Children\u2019s Hospital, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"17","key":"zoi261065r1","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2023.4809","article-title":"National trends in mental health-related emergency department visits among youth, 2011-2020.","volume":"329","author":"Bommersbach","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"zoi261065r4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1576","article-title":"Growth and distribution of child psychiatrists in the United States: 2007-2016.","volume":"144","author":"McBain","year":"2019","journal-title":"Pediatrics"},{"issue":"8","key":"zoi261065r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.26402","article-title":"Comprehensiveness of state insurance laws and perceived access to pediatric mental health care.","volume":"7","author":"Foster","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi261065r6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jamapediatrics.2018.5399","article-title":"US national and state-level prevalence of mental health disorders and disparities of mental health care use in children.","volume":"173","author":"Whitney","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"3","key":"zoi261065r7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057383","article-title":"Follow-up after pediatric mental health emergency visits.","volume":"151","author":"Hoffmann","year":"2023","journal-title":"Pediatrics"},{"issue":"12","key":"zoi261065r8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/jcm7120543","article-title":"Examining the association and directionality between mental health disorders and substance use among adolescents and young adults in the U.S. and Canada\u2014a systematic review and meta-analysis.","volume":"7","author":"Esmaeelzadeh","year":"2018","journal-title":"J Clin Med"},{"issue":"50","key":"zoi261065r9","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.15585\/mmwr.mm7150a2","article-title":"Drug overdose deaths among persons aged 10-19 years\u2014United States, July 2019-December 2021.","volume":"71","author":"Tanz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"zoi261065r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.30280","article-title":"Trends and disparities in treatment for co-occurring major depression and substance use disorders among US adolescents from 2011 to 2019.","volume":"4","author":"Lu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi261065r11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2025-073172","article-title":"promoting optimal development: screening for mental health, emotional, and behavioral problems: clinical report.","volume":"156","author":"Weitzman","year":"2025","journal-title":"Pediatrics"},{"issue":"20","key":"zoi261065r12","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1001\/jama.2020.6774","article-title":"Primary care\u2013based interventions to prevent illicit drug use in children, adolescents, and young adults: US Preventive Services Task Force recommendation statement.","volume":"323","author":"Krist","year":"2020","journal-title":"JAMA"},{"issue":"16","key":"zoi261065r15","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2025.15338","article-title":"Mental health and substance use linked in new survey.","volume":"334","author":"Anderer","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"zoi261065r16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaac.2016.01.006","article-title":"Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the National Comorbidity Survey\u2013Adolescent Supplement.","volume":"55","author":"Conway","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"zoi261065r17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaac.2017.05.004","article-title":"Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis.","volume":"56","author":"Groenman","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi261065r18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/jamapediatrics.2025.4105","article-title":"Opioid use disorder and nonfatal opioid-involved overdose among Medicaid-enrolled US youth, 2020-2023.","volume":"180","author":"Chen","year":"2026","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi261065r19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/cap.2022.0016","article-title":"The impact of pharmacotherapy of childhood-onset psychiatric disorders on the development of substance use disorders.","volume":"32","author":"Wilens","year":"2022","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"zoi261065r20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1037\/a0026929","article-title":"Onset of alcohol or substance use disorders following treatment for adolescent depression.","volume":"80","author":"Curry","year":"2012","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"zoi261065r21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/00325481.2019.1546533","article-title":"Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014.","volume":"131","author":"Carr\u00e0","year":"2019","journal-title":"Postgrad Med"},{"issue":"4","key":"zoi261065r22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis.","volume":"76","author":"Gobbi","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi261065r23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/archpsyc.59.11.1039","article-title":"Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders.","volume":"59","author":"Brook","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"zoi261065r24","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1016\/S2468-2667(25)00115-X","article-title":"Adolescent substance use patterns and subsequent risk of mental and behavioural disorders, substance use, and suicidal behaviour: a cohort study.","volume":"10","author":"Hansen","year":"2025","journal-title":"Lancet Public Health"},{"issue":"5","key":"zoi261065r25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15585\/mmwr.mm7305a1","article-title":"Characteristics of alcohol, marijuana, and other drug use among persons aged 13\u201318 years being assessed for substance use disorder treatment\u2014United States, 2014\u20132022.","volume":"73","author":"Connolly","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"zoi261065r28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jaac.2012.11.014","article-title":"Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(\u00ae)) System.","volume":"52","author":"Zosel","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi261065r29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.drugalcdep.2014.02.011","article-title":"Prescription drug misuse among homeless youth.","volume":"138","author":"Rhoades","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"zoi261065r14","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi261065r2","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Accessed October 10, 2025. https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\/national-releases"},{"key":"zoi261065r3","unstructured":"American Academy of Pediatrics. AAP-AACAP-CHA Declaration of a National Emergency in Child and Adolescent Mental Health. Accessed November 14, 2025. https:\/\/www.aap.org\/en\/advocacy\/child-and-adolescent-healthy-mental-development\/aap-aacap-cha-declaration-of-a-national-emergency-in-child-and-adolescent-mental-health\/?srsltid=AfmBOooVdKySGn1h17di_uInpt_ldLlDoELuKkV0bJgQB8_Q37AFmDzW"},{"key":"zoi261065r13","unstructured":"Center for Behavioral Health Statistics and Quality. 2024 National Survey on Drug Use and Health (NSDUH): methodological summary and definitions. 2025. Accessed May 22, 2026.  https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\/methodology"},{"key":"zoi261065r26","unstructured":"Centers for Disease Control and Prevention. Data and statistics on children\u2019s mental health. Accessed May 22, 2026. https:\/\/www.cdc.gov\/children-mental-health\/data-research\/index.html"},{"key":"zoi261065r27","unstructured":"National Survey of Children\u2019s Health Adolescent Mental and Behavioral Health. 2023. Accessed May 22, 2026. https:\/\/mchb.hrsa.gov\/sites\/default\/files\/mchb\/data-research\/nsch-data-brief-adolescent-mental-behavioral-health-2023.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2855389\/toce_2026_oi_261065_1791554548.25953.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:30:31Z","timestamp":1792164631000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2855389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.39343","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}